With a focus on collaboration and partnership, we work closely with healthcare providers to develop customized solutions that meet the unique needs of their patients and communities.
The Canadian government announced plans to invest $2.2 billion over seven years to support Canada’s life sciences and biotech research and development. The funding will be used to support research into new treatments and technologies and to attract and retain talent in the life sciences sector.
The US government announced it would allocate $1.6 billion to expand COVID-19 testing in schools and underserved communities. This funding will be used to support the development and deployment of new COVID-19 tests, including rapid antigen tests that can provide results in as little as 15 minutes.
The Biden administration announced plans to invest $10 billion in domestic manufacturing of critical medical supplies, including drugs and active pharmaceutical ingredients. The funding is intended to help address supply chain vulnerabilities exposed during the COVID-19 pandemic.
The Canadian government announced that it would invest $25 million in a new biomanufacturing facility in Montreal, producing mRNA vaccines and other biologic drugs. The facility will be operated by biotech company AbCellera and is expected to create over 200 jobs in the region.